HR 1504
107th Congress
House
Taxation
AIDS (Disease)
Biotechnology
Business income tax
Clinical trials
Commerce
Communicable diseases
Developing countries
Drug industry
Economics and Public Finance
Government trust funds
Health
Human immunodeficiency viruses
Income tax
International Affairs
International agencies
International cooperation
Malaria
Medical research
Microbiological research
Vaccines for the New Millennium Act of 2001
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 25, 2001
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Apr 5, 2001
Sponsor introductory remarks on measure. (CR E554)
Apr 4, 2001
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and International Relations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 4, 2001
Introduced in House
Plain-English summary
Vaccines for the New Millennium Act of 2001 - Amends the Internal Revenue Code to allow a limited business credit for the costs medical research related to developing vaccines against widespread diseases. Defines widespread diseases as malaria, tuberculosis, HIV, or any infectious disease (of a single etiology) which, according to the World Health Organization, causes over one million human deaths annually.
Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.
Establishes the Lifesaving Vaccine Purchase Fund.
Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines.
What's happening now
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Committees of jurisdiction
4
Cosponsors
1